Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Nuvation Bio (NUVB) Non Operating Investment Income (2023 - 2025)

Nuvation Bio (NUVB) has disclosed Non Operating Investment Income for 3 consecutive years, with $3000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Non Operating Investment Income fell 40.0% to $3000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $5000.0, a 141.67% increase, with the full-year FY2025 number at $5000.0, up 141.67% from a year prior.
  • Non Operating Investment Income was $3000.0 for Q4 2025 at Nuvation Bio, up from -$1000.0 in the prior quarter.
  • In the past five years, Non Operating Investment Income ranged from a high of $12000.0 in Q3 2023 to a low of -$99000.0 in Q2 2023.
  • A 3-year average of -$10444.4 and a median of $1000.0 in 2024 define the central range for Non Operating Investment Income.
  • Peak YoY movement for Non Operating Investment Income: plummeted 191.67% in 2024, then skyrocketed 200.0% in 2025.
  • Nuvation Bio's Non Operating Investment Income stood at $12000.0 in 2023, then crashed by 58.33% to $5000.0 in 2024, then crashed by 40.0% to $3000.0 in 2025.
  • Per Business Quant, the three most recent readings for NUVB's Non Operating Investment Income are $3000.0 (Q4 2025), -$1000.0 (Q2 2025), and $3000.0 (Q1 2025).